Literature DB >> 24269390

[Orbital alveolar rhabdomyosarcoma masked by ethmoid sinusitis in a 25-year-old].

E Sanz-Marco1, E España2, A Alamar3, J Pérez-Rojas4, M J López-Prats5, M Díaz-Llopis6.   

Abstract

CASE REPORT: A 25-year-old woman with right subacute sinusitis, complained about discomfort in her right eye. Clinical manifestations and computed tomography were suggestive of sub-periosteal orbital ethmoid wall abscess, for which the patient underwent urgent drainage. A solid tumor was found, with a positive biopsy for alveolar rhabdomyosarcoma. Complete remission and resolution of orbital symptoms were achieved with chemotherapy and radiation therapy. DISCUSSION: Alveolar orbital rhabdomyosarcoma in adults is uncommon. Rhabdomyosarcoma has a high risk of spreading. It can simulate a sinusitis, as in our patient, early diagnosis and early treatment being especially important in these patients.
Copyright © 2010 Sociedad Española de Oftalmología. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Apex; Masked orbital rhabdomyosarcoma; Rabdomiosarcoma; Rabdomiosarcoma alveolar; Rabdomiosarcoma orbitario enmascarado; Rhabdomyosarcoma; Rhabdomyosarcoma alveolar; Sinusitis; Ápex

Mesh:

Year:  2012        PMID: 24269390     DOI: 10.1016/j.oftal.2012.10.012

Source DB:  PubMed          Journal:  Arch Soc Esp Oftalmol        ISSN: 0365-6691


  3 in total

1.  Distinguishing the dominant species of pathogen in ethmoidal sinusitis by sequencing DNA dataset analysis.

Authors:  Junyi Zhang; Shuai He; Yunchuan Li; Minggang Lv; Hongzheng Wei; Bin Qu; Yani Zheng; Chunhua Hu
Journal:  Exp Ther Med       Date:  2018-09-11       Impact factor: 2.447

2.  Adult Rhabdomyosarcoma of Ethmoid Sinus Recurring as an Orbital Mass.

Authors:  Bahram Eshraghi; Kambiz Ameli; Pasha Anvari
Journal:  J Clin Diagn Res       Date:  2016-04-01

3.  One-year survivor of adult alveolar rhabdomyosarcoma of the maxillary sinus with orbital extension: Case report.

Authors:  Jin-Ho Joo; Ji Sang Han; Shin-Myeong Choi; In-Ki Park; Jae-Ho Shin
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.